References
Du-Thanh A, Kluger N, Bensalleh H, et al. Drug-induced acneiform eruption. Am J Clin Dermatol 2011; 12(4): 233–45
Common terminology criteria for adverse events (CTCAE), version 4.03. Bethesda (MD): U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 2010 Jun 14
Perez-Soler R, Saltz L. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining? J Clin Oncol 2005; 23: 5235–46
Michot C, Guillot B, Dereure O. Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents. Dermatology 2010; 220: 49–50
Scope A, Agero AL, Dusza AL, et al. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol 2007; 25: 5390–6
Deplanque G, Chavaillon J, Vergnenegre A, et al. CYTAR: a randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib-induced folliculitis in non-small cell lung cancer patients [abstract no. 9019]. J Clin Oncol 2010 May 20; 28(15 Suppl.): 9019
Rights and permissions
About this article
Cite this article
A wide range of drugs may potentially induce acne. Drugs Ther Perspect 28, 21–24 (2012). https://doi.org/10.2165/11606210-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11606210-000000000-00000